Effect of oxycodone combined with sufentanil patient-controlled intravenous analgesia after cesarean section

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-16008708

Enrollment

Unknown

Registered

2016-06-22

Start date

2016-06-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

OSF1:PCIA

OSF2:PCIA

Group SF:PCIA

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: primiparas undergoing elective caesarean section with spinal anesthesia

Exclusion criteria

Exclusion criteria: preeclampsia, pregnancy complicated with diabetes mellitus or cardiac disease, a long history of opioids usage, preoperative use of analgesic drugs within 24 h. Patients who cannot use numerical rating scale (NRS) were also excluded.

Design outcomes

Primary

Measure	Time frame
VAS (Visual Analogue Scale);	—

Countries

China

Contacts

Public ContactShen Sun

Obstetrics and Gynecology Hospital of Fudan University

sunshen1980@126.com+86 15800391773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026